Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$0.72 - $1.15 $2,880 - $4,600
-4,000 Reduced 25.4%
11,747 $11,000
Q3 2023

Nov 14, 2023

SELL
$1.08 - $2.54 $8,632 - $20,302
-7,993 Reduced 33.67%
15,747 $18,000
Q2 2023

Aug 21, 2023

SELL
$2.31 - $3.06 $94,248 - $124,848
-40,800 Reduced 63.22%
23,740 $58,000
Q1 2023

May 09, 2023

SELL
$3.13 - $7.31 $3,176 - $7,419
-1,015 Reduced 1.55%
64,540 $202,000
Q4 2022

Feb 14, 2023

BUY
$6.39 - $8.8 $36,978 - $50,925
5,787 Added 9.68%
65,555 $461,000
Q3 2022

Nov 18, 2022

BUY
$7.99 - $10.75 $29,914 - $40,248
3,744 Added 6.68%
59,768 $515,000
Q2 2022

Aug 15, 2022

BUY
$4.58 - $17.13 $182,462 - $682,442
39,839 Added 246.15%
56,024 $463,000
Q1 2022

May 16, 2022

SELL
$12.3 - $18.33 $38,794 - $57,812
-3,154 Reduced 16.31%
16,185 $269,000
Q4 2021

Feb 15, 2022

BUY
$7.44 - $16.72 $7,477 - $16,803
1,005 Added 5.48%
19,339 $323,000
Q3 2021

Nov 15, 2021

SELL
$4.85 - $9.73 $140,329 - $281,527
-28,934 Reduced 61.21%
18,334 $158,000
Q2 2021

Aug 16, 2021

SELL
$4.93 - $6.46 $507 - $665
-103 Reduced 0.22%
47,268 $257,000
Q3 2020

Nov 17, 2020

BUY
$4.36 - $5.5 $36,706 - $46,304
8,419 Added 21.61%
47,371 $229,000
Q2 2020

Aug 17, 2020

SELL
$3.6 - $7.75 $29,412 - $63,317
-8,170 Reduced 17.34%
38,952 $202,000
Q1 2020

May 13, 2020

BUY
$2.77 - $5.75 $65,083 - $135,102
23,496 Added 99.45%
47,122 $205,000
Q4 2019

Feb 14, 2020

SELL
$2.5 - $4.26 $807 - $1,375
-323 Reduced 1.35%
23,626 $95,000
Q2 2019

Aug 14, 2019

BUY
$7.09 - $21.9 $31,500 - $97,301
4,443 Added 22.78%
23,949 $185,000
Q1 2019

May 09, 2019

BUY
$16.83 - $23.75 $192,585 - $271,771
11,443 Added 141.92%
19,506 $346,000
Q4 2018

Feb 13, 2019

BUY
$20.21 - $32.9 $5,719 - $9,310
283 Added 3.64%
8,063 $190,000
Q3 2018

Nov 14, 2018

BUY
$15.5 - $21.41 $120,590 - $166,569
7,780 New
7,780 $167,000

Others Institutions Holding KZR

About Kezar Life Sciences, Inc.


  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $510M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.